202 related articles for article (PubMed ID: 10565227)
1. [Successful immunosuppressive therapy for a patient with hypoplastic myelodysplastic syndrome].
Takanashi M; Kadono Y; Tabata Y; Hibi S
Rinsho Ketsueki; 1999 Oct; 40(10):1093-9. PubMed ID: 10565227
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
Tsuzuki M; Okamoto M; Yamaguchi T; Ino T; Ezaki K; Hirano M
Rinsho Ketsueki; 1997 Sep; 38(9):745-51. PubMed ID: 9364865
[TBL] [Abstract][Full Text] [Related]
3. [Outcome of immunosuppressive therapy for myelodysplastic syndromes: results of 12 cases from a single institution].
Miyata A; Yasuda Y; Fujii S; Kikuchi T
Rinsho Ketsueki; 2002 Oct; 43(10):911-7. PubMed ID: 12462026
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome.
Biesma DH; van den Tweel JG; Verdonck LF
Cancer; 1997 Apr; 79(8):1548-51. PubMed ID: 9118037
[TBL] [Abstract][Full Text] [Related]
5. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99.
Passweg JR; Giagounidis AA; Simcock M; Aul C; Dobbelstein C; Stadler M; Ossenkoppele G; Hofmann WK; Schilling K; Tichelli A; Ganser A
J Clin Oncol; 2011 Jan; 29(3):303-9. PubMed ID: 21149672
[TBL] [Abstract][Full Text] [Related]
7. [Successful combined therapy with ATG, cyclosporin and G-CSF for both liver dysfunction and bone marrow failure in hepatitis-associated aplastic anemia].
Adachi Y; Usuki K; Kazama H; Iki S; Matsuya S; Urabe A
Rinsho Ketsueki; 2001 Sep; 42(9):691-5. PubMed ID: 11680980
[TBL] [Abstract][Full Text] [Related]
8. Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndrome.
Berer A; Ohler L; Simonitsch I; Thalhammer R; Lechner K; Geissler K
Wien Klin Wochenschr; 1999 Oct; 111(19):815-8. PubMed ID: 10568013
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of cyclosporin A therapy in patients with myelodysplastic syndrome].
Kokhno AV; Parovichnikova EN; Mikhaĭlova EA; Ustinova EN; Kaplanskaia IB; Dvirnyk VN; Ol'shanskaia IuV; Domracheva EV; Savchenko VG
Ter Arkh; 2010; 82(8):48-53. PubMed ID: 20873246
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressive treatment of the myelodysplastic syndrome].
Larsen MS; Hasselbalch HC
Ugeskr Laeger; 2003 Jun; 165(26):2654-7. PubMed ID: 12886548
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic syndrome with der (1;7) transformed from aplastic anemia 42 years after onset].
Kanemura N; Tsurumi H; Hara T; Yamada T; Moriwaki H
Rinsho Ketsueki; 2005 May; 46(5):372-4. PubMed ID: 16444972
[TBL] [Abstract][Full Text] [Related]
12. [Curative effects of cyclosporin A therapy upon myelodysplastic syndrome].
Chen SC; Jiang B; Da WM; Gong M; Guan M
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2711-5. PubMed ID: 17199984
[TBL] [Abstract][Full Text] [Related]
13. Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
Orimoto M; Maeda M; Cai LZ; Hayakawa J; Ueda T; Migita M; Asano T
Med Pediatr Oncol; 2003 May; 40(5):334-5. PubMed ID: 12652627
[No Abstract] [Full Text] [Related]
14. Hypoplastic myelodysplastic syndrome transformed in acute myeloid leukemia after androgens and cyclosporin. A treatment.
Gologan R; Ostroveanu D; Dobrea C; Gioadă L
Rom J Intern Med; 2003; 41(4):447-55. PubMed ID: 15526527
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
Goldenberg NA; Graham DK; Liang X; Hays T
Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
[TBL] [Abstract][Full Text] [Related]
16. Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes.
Yazji S; Giles FJ; Tsimberidou AM; Estey EH; Kantarjian HM; O'Brien SA; Kurzrock R
Leukemia; 2003 Nov; 17(11):2101-6. PubMed ID: 12931212
[TBL] [Abstract][Full Text] [Related]
17. [Effective treatment combining antithymocyte globulin, cyclosporin A, and granulocyte colony-stimulating factor for atypical paroxysmal nocturnal hemoglobinuria accompanied by bone marrow hypoplasia].
Noji H; Shichishima T; Ishikawa S; Kai T; Saitoh Y; Maruyama Y
Rinsho Ketsueki; 1999 Mar; 40(3):240-3. PubMed ID: 10222633
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive therapy with antithymocyte globulin and cyclosporine for prolonged marrow failure after hemophagocytic syndrome.
Kaito K; Otsubo H; Takei Y; Usui N; Kobayashi M
Ann Hematol; 2003 Nov; 82(11):699-701. PubMed ID: 12961029
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndrome.
Arber C; Buser A; Heim D; Gratwohl A; Tichelli A; Passweg JR
Eur J Haematol; 2006 Mar; 76(3):255-7. PubMed ID: 16451398
[TBL] [Abstract][Full Text] [Related]
20. The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Xiao L; Qi Z; Qiusheng C; Li X; Luxi S; Lingyun W
Am J Hematol; 2012 Jan; 87(1):26-31. PubMed ID: 22038646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
